Taiwan-Asia Semiconductor Corp. (TASC) is positioning itself for robust growth in 2025, leveraging its subsidiaries to drive innovation and market expansion. The company projects a 20% annual increase in capacity utilization, with full-year revenue expected to surpass 2024 levels. Recent government subsidies for blood glucose monitoring devices have further bolstered its development efforts.